Ronald Kirk Huntsman, Chief Executive Officer at Vivos Therapeutics, Inc. (VVOS), bought 5,000 shares at $3.00 ($15K) on 2021-08-17, disclosed to the SEC on 2021-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VVOS | BUY | 2023-06-15 | $5K | — | Filing → |
| VVOS | BUY | 2022-12-28 | $10K | — | Filing → |
| VVOS | BUY | 2022-06-03 | $24K | — | Filing → |